«Radioimmunoprecipitation Assay

Below is an extended Radioimmunoprecipitation Assay patents listing. Click here to return to the Radioimmunoprecipitation Assay main in depth entry.

Patents :
US Patent No.	Title
6610504	Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
6783758	Diagnosis and treatment of malignant neoplasms
6790606	Extracellular matrix signaling molecules
6797696	Diagnosis and treatment of malignant neoplasms
6812206	Diagnosis and treatment of malignant neoplasms
6815415	Diagnosis and treatment of malignant neoplasms
6835370	Diagnosis and treatment of malignant neoplasms
6863880	Methods to diagnose a required regulation of trophoblast invasion
6908618	Production of novel bovine respiratory syncytial viruses from cDNAs
6911307	METHOD OF DETECTION IN VITRO OF A TARGET SUBSTANCE IN A SAMPLE COMPRISING THE LABELLING OF SAID SUBSTANCE WITH A REPORTER GENE AND WITH THE SEQUENCES NECESSARY FOR THE EXPRESSION OF SAID REPORTER GENE IN VITRO
6919331	Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
6774117	MN gene and protein
6770797	Non-Transgenic nonhuman model for Alzheimer's Disease using a AD7c-NTP nucleic acid
6770438	MN gene and protein
6664041	Method for preparing a viral extract containing HIV-II RNA
6673903	Mammalian cell cycle protein
6692749	Non-splicing variants of gp350/220
6696289	Replication-competent recombinant Sabin type 1 strain of poliovirus
6696548	Antibodies for recognition of alk protein tyrosine/kinase receptor
6710173	Stabilized viral envelope proteins and uses thereof
6713609	Monoclonal antibodies to type I interferon receptor
6720158	Splice variants of BRCA1
6759385	Methods to treat undesirable immune responses
6764833	Mutated Src oncogene composition and methods
6930176	Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
6936261	Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
7192593	Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
7232683	Extracellular matrix signaling molecules
7250171	Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
7267820	Neurotransmission disorders
7276581	Mutated Src oncogene composition and methods
7304150	Methods and compositions for the prevention and treatment of anemia
7314631	Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
7319094	Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition
7326540	Methods for identifying compounds that modulate stabilization of secretase-associated proteins
7341731	HIV-2 antigen compositions
7186514	MN gene and protein
7151172	Attenuated vif DNA immunization cassettes for genetic vaccines
7148323	Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
7022324	Stabilized viral envelope proteins and uses thereof
7022327	Recombinant birnavirus vaccine
7041293	HIV env antibodies
7056508	Receptor-type phosphotyrosine phosphatase-kappa antibodies
7056733	Nucleic acids encoding Sarcocystis neurona antigen and uses thereof
7094556	Diagnosis and treatment of malignant neoplasms
7115363	Retrovirus capable of causing AIDS, means and methods for detecting it in vitro
7115715	Anti-idiotype antibodies to MN proteins and MN polypeptides
7135187	System for production of helper dependent adenovirus vectors based on use of endonucleases
7148016	Immunoassays to detect diseases or disease susceptibility traits
7416840	Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.